Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Cash from Financing Activities (2016 - 2026)

Biomerica's Cash from Financing Activities history spans 16 years, with the latest figure at $61000.0 for Q1 2026.

  • Quarterly results put Cash from Financing Activities at $61000.0 for Q1 2026, down 96.49% from a year ago — trailing twelve months through Feb 2026 was $1.5 million (down 84.4% YoY), and the annual figure for FY2025 was $2.1 million, up 2706.17%.
  • Cash from Financing Activities for Q1 2026 was $61000.0 at Biomerica, down from $482000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $7.4 million in Q2 2023 to a low of -$5000.0 in Q2 2025.
  • The 4-year median for Cash from Financing Activities is $482000.0 (2025), against an average of $1.2 million.
  • The sharpest move saw Cash from Financing Activities surged 19414.14% in 2023, then crashed 96.49% in 2026.
  • Year by year, Cash from Financing Activities stood at $237000.0 in 2022, then surged by 3001.27% to $7.4 million in 2023, then tumbled by 93.44% to $482000.0 in 2025, then tumbled by 87.34% to $61000.0 in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $61000.0, $482000.0, and $920000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.